dissolved in 10 mM phosphate buffer (pH 7.0) containing 0.1 M
NaCl and 0.1 mM EDTA. The solution was kept at 85◦◦C or 70 ◦C
for 5 min and the temperature was decreased to 10 C at a rate
102.8, 110.1, 113.6, 118.7, 124.9, 127.1, 127.2, 127.5, 127.9, 128.3,
128.4, 130.0, 130.3, 130.5, 134.3, 135.1, 135.3, 140.3, 144.3, 150.0,
154.7, 159.0, 159.0, 162.5. ESI-MS m/z calcd for C40H36N2NaO8
[M+Na] 695.2364, found 695.2579.
◦
of 0.5 C min-1. After that, UV absorbance was measured at an
interval of 1 ◦C by increasing the temperature to 85 ◦C or 70 ◦C. An
UV melting curve was obtained by smoothing the original data
7 times using Dtavitzky–Golay method (25 points). Differentiation
of this UV melting curve gave the Tm value. concentration of
modified oligonucleotides was calculated using the e values of the
unmodified oligonucleotides. The average data of the Tm values
thus obtained was calculated and used for discussion.
2¢-O-Phenyl-5¢-O-(4,4¢-dimethoxytrityl)uridine-3¢-(2-cyanoethyl
N,N-diisopropyl)phosphoramidite (4a)
Compound 3a (100 mg, 0.16 mmol) was coevaporated thrice
with each of anhydrous pyridine and anhydrous toluene, and
then dissolved in anhydrous CH2Cl2 (400 ml, 0.4 M) under
argon atmosphere. Diisopropylamine (14 ml, 0.10 mmol), 1H-
tetrazole (6.7 mg, 0.10 mmol) and 2-cyanoethyl N,N,N¢,N¢-
tetraisopropylphosphorodiamidite (60.3 mg, 0.20 mmol) were
added to this solution. After the reaction, the mixture was diluted
with CH2Cl2 and quenched by NaHCO3 (aq). The solution was
extracted with CH2Cl2 and washed with brine. The organic layer
was dried over anhydrous Na2SO4. After filtration, the filtrate was
evaporated in vacuo. The residue was purified by RP-HPLC using
acetonitrile as an eluent to yield compound 4a (75%).
2¢-O-Phenyl-5¢-O-(4,4¢-dimethoxytrityl)uridine (3a)
Compound 2a (100 mg, 0.32 mmol) was coevaporated 3 times with
anhydrous pyridine and dissolved in anhydrous pyridine (800 ml,
0.4 M) under argon atmosphere. 4,4¢-Dimethoxytrityl chloride
(126.9 mg, 0.37 mmol) was added to the above solution, and the
mixture was stirred for 4 h. After the reaction, NaHCO3 (aq)
was added to the mixture and the solution was extracted with
ethyl acetate. The organic layer was washed thrice with brine
and dried over anhydrous Na2SO4. After filtration, the filtrate
was evaporated in vacuo. The residue was purified by N60 silica
gel column chromatography (hexane/CHCl3 50–75%) to give
compound 3a (91%).
1H NMR (CDCl3, 500 MHz) d 0.99 (6H, d, J = 6.6 Hz), 1.09
(6H, t, J = 7.6 Hz), 1.27 (2H, J = 6.8 Hz), 2.45 (2H, m), 3.43–3.75
(6H, m), 3.80 (6H, d, J = 4.4 Hz), 4.35 (1H, t, J = 2.7 Hz), 4.74
(1H, m), 5.00 (1H, d, J = 4.2 Hz), 5.28 (1H, t, J = 9.3 Hz), 6.21 (1H,
d, J = 3.7 Hz), 6.85 (4H, t, J = 8.1 Hz), 7.03 (3H, m), 7.24–7.33
(9H, m), 7.41 (2H, m), 7.95(1H, t, J = 8.3 Hz);13C NMR (CDCl3,
125 MHz) d 20.3, 20.4, 24.6, 24.7, 43.2, 43.3, 55.4, 55.4, 55.4, 58.3,
58.5, 61.9, 80.2, 83.0, 87.4, 88.0, 102.6, 113.5, 116.1, 116.3, 117.8,
122.1, 122.2, 127.4, 128.2, 128.4, 128.4, 129.7, 130.4, 130.4, 135.1,
135.2, 140.2, 144.3, 150.2, 157.9, 158.9, 162.9; 31P NMR (CDCl3,
203 MHz) d 151.9, 151.7. ESI-MS m/z calcd for C45H52N4O9P
[M+H] 823.3466, found 823.3455.
1H NMR (CDCl3, 500 MHz) d 3.56–3.63 (2H, m), 3.80 (6H, s),
4.24–4.25 (1H, m), 4.68 (1H, q, J = 5.9 Hz), 4.88 (1H, t, J = 4.0
Hz), 5.30 (1H,d, J = 8.1 Hz), 6.19 (1H, d, J = 3.9 Hz), 6.85 (4H,
d, J = 8.6 Hz), 7.08 (3H, d, J = 7.6 Hz), 7.26–7.35 (9H, m), 7.40
(2H, d, J = 7.6 Hz), 7.95 (1H, d, J = 8.3 Hz), 8.30 (1H, s); 13C
NMR (CDCl3) d 55.4, 62.3, 69.9, 81.3, 83.7, 87.3, 102.7, 113.5,
116.6, 123.3, 127.4, 128.2, 128.3, 130.1, 130.3, 130.4, 135.1, 135.3,
140.3, 144.4, 150.0, 157.0, 158.9, 159.0, 162.7. ESI-MS m/z calcd
for C36H34N2NaO8 [M+Na] 645.2207, found 645.2041.
2¢-O-(1-Naphthyl)-5¢-O-(4,4¢-dimethoxytrityl)-3¢-(2-cyanoethyl
N,N-diisopropyl)phosphoramidite (4b)
2¢-O-(1-Naphthyl)-5¢-O-(4,4¢-dimethoxytrityl)uridine (3b)
Compound 4b was synthesized from 3b according to the same
procedure as that described for compound 4a.
Compound 3b was synthesized from 2b according to the same
procedure as that described for compound 3a.
1H NMR (CDCl3, 500 MHz) d 0.72 (3H, d, J = 6.6 Hz), 0.93
(3H, d, J = 6.6 Hz), 0.99 (3H, d, J = 6.6 Hz), 1.28 (3H, t, J = 6.8
Hz), 2.15 (1H, m), 2.35 (1H, m), 3.38 (2H, m), 3.49–3.62 (3H, m),
3.69 (1H, t, J = 9.2 Hz), 3.80 (6H, d, J = 4.6 Hz), 4.53 (1H, m),
4.90 (1H, m), 5.15 (1H, m), 5.32 (1H, dd, J = 8.2, 16.5 Hz), 6.41
(1H, dd, J = 4.0, 8.2 Hz), 6.86 (4H, t, J = 8.2 Hz), 7.10 (1H, dd, J =
7.6, 12.5 Hz), 7.26–7.49 (14H, m), 7.78 (1H, dd, J = 7.6, 15.6 Hz),
1H NMR (CDCl3, 500 MHz) d 3.60–3.68 (2H, m), 3.80 (6H, s),
4.39–4.40 (1H, m), 4.80 (1H, t, J = 4.9 Hz), 5.08 (1H, t, J = 4.4 Hz),
5.30 (1H, d, J = 8.1 Hz), 6.37 (1H, d, J = 3.9 Hz), 6.86 (4H, dd, J =
2.7 Hz, 9.2 Hz), 7.12 (1H, d, 7.8 Hz), 7.26–7.33 (7H, m), 7.38–7.42
(3H, m), 7.52–7.58 (3H, m), 7.84–7.86 (1H, m), 7.93–7.95 (1H, d,
J = 8.3 Hz), 8.19–8.20 (1H, d, 9.3 Hz); 13C NMR (CDCl3) d 55.4,
55.5, 62.6, 70.1, 81.5, 84.0, 87.1, 87.5, 102.8, 108.1, 113.6, 121.5,
122.9, 125.7, 125.8, 126.3, 127.0, 127.5, 128.0, 128.3, 130.3, 134.9,
135.1, 135.3, 140.2, 144.3, 150.0, 152.6, 159.0, 162.5. ESI-MS m/z
calcd for C40H36N2NaO8 [M+Na] 695.2364, found 695.2382.
7.99 (1H, dd, J = 8.2, 13.3 Hz), 8.26 (1H, dd, J = 3.8, 7.7 Hz); 13
C
NMR (CDCl3, 125 MHz) d 20.0, 20.4, 24.1, 24.6, 43.2, 43.3, 43.4,
55.4, 57.7, 57.8, 58.1, 58.2, 62.2, 70.5, 70.6, 70.8, 70.9, 79.4, 80.0,
83.4, 83.7, 87.4, 87.5, 87.7, 102.8, 106.8, 113.3, 113.5, 117.6, 117.7,
121.5, 121.6, 122.3, 122.5, 125.5, 125.6, 125.8, 126.0, 126.6, 126.7,
127.4, 127.6, 128.2, 128.4, 129.3, 130.3, 134.7, 135.1, 135.3, 140.2,
144.3, 144.4, 150.5, 153.1, 153.2, 158.9, 163.2; 31P NMR (CDCl3,
203 MHz) d 151.8. ESI-MS m/z calcd for C49H54N4O9P [M+H]
873.3623, found 873.3533.
2¢-O-(2-Naphthyl)-5¢-O-(4,4¢-dimethoxytrityl)uridine (3c)
Compound 3c was synthesized from 2c according to the same
procedure as that described for compound 3a.
1H NMR (CDCl3, 500 MHz) d 3.57–3.66 (2H, m), 3.79 (6H, s),
4.29–4.30 (1H, m), 4.76 (1H, t, J = 5.0 Hz), 5.06 (1H, t, J = 4.2 Hz),
5.33 (1H, d, J = 8.1 Hz), 6.28 (1H, d, J = 3.7 Hz), 6.86 (4H, d, J =
7.8 Hz), 7.24–7.28 (2H, m), 7.31–7.34 (6H, m), 7.38–7.47 (5H, m),
7.66 (1H, d, J = 8.3 Hz), 7.79–7.81 (2H, m), 8.00 (1H, d, J = 8.3
Hz); 13C NMR (CDCl3) d 55.4, 62.5, 69.9, 81.1, 83.7, 87.2, 87.6,
2¢-O-(2-Naphthyl)-5¢-O-(4,4¢-dimethoxytrityl)uridine-3¢-(2-
cyanoethyl N,N-diisopropyl)phosphoramidite (4c)
Compound 4c was synthesized from 3c using the same procedure
as that described for compound 4a.
216 | Org. Biomol. Chem., 2011, 9, 210–218
This journal is
The Royal Society of Chemistry 2011
©